AA
PFE icon

Argent Advisors’s Pfizer PFE Stock Holding History

Argent Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Buy
109,643
+2,913
+3% +$76.2K 0.66% 37
2026
Q1 		$3M Buy
106,730
+6,333
+6% +$169K 0.82% 33
2025
Q4 		$2.5M Sell
100,397
-8,940
-8% -$225K 0.7% 37
2025
Q3 		$2.79M Buy
109,337
+5,318
+5% +$131K 0.82% 33
2025
Q2 		$2.52M Buy
104,019
+6,136
+6% +$143K 0.78% 35
2025
Q1 		$2.48M Buy
97,883
+10,923
+13% +$286K 0.83% 30
2024
Q4 		$2.31M Sell
86,960
-12,178
-12% -$330K 0.86% 29
2024
Q3 		$2.87M Buy
99,138
+8,001
+9% +$233K 1.07% 19
2024
Q2 		$2.55M Buy
91,137
+10,584
+13% +$291K 1.01% 20
2024
Q1 		$2.24M Buy
80,553
+13,515
+20% +$375K 0.88% 26
2023
Q4 		$1.93M Sell
67,038
-1,868
-3% -$56.5K 0.85% 27
2023
Q3 		$2.28M Buy
68,906
+5,468
+9% +$193K 1.04% 20
2023
Q2 		$2.33M Buy
63,438
+3,034
+5% +$118K 1.07% 18
2023
Q1 		$2.46M Buy
60,404
+3,572
+6% +$154K 1.18% 18
2022
Q4 		$2.91M Buy
56,832
+6
+0% +$288 1.51% 15
2022
Q3 		$2.49M Buy
56,826
+1,789
+3% +$86.9K 1.45% 15
2022
Q2 		$2.89M Buy
55,037
+2,401
+5% +$122K 1.62% 14
2022
Q1 		$2.73M Sell
52,636
-7,332
-12% -$380K 1.46% 15
2021
Q4 		$3.54M Buy
59,968
+2,339
+4% +$116K 1.91% 10
2021
Q3 		$2.48M Buy
57,629
+7,956
+16% +$352K 1.42% 15
2021
Q2 		$1.95M Buy
49,673
+3,318
+7% +$129K 1.18% 16
2021
Q1 		$1.68M Buy
46,355
+4,068
+10% +$144K 1.08% 20
2020
Q4 		$1.56M Sell
42,287
-1,688
-4% -$61.9K 0.95% 24
2020
Q3 		$1.53M Buy
43,975
+1,388
+3% +$48.7K 1.05% 23
2020
Q2 		$1.32M Buy
42,587
+2,268
+6% +$77.1K 1.01% 21
2020
Q1 		$1.25M Buy
40,319
+13,395
+50% +$456K 1.25% 19
2019
Q4 		$1.01M Buy
+26,924
New +$959K 0.76% 29

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Argent Advisors's PFE Position: Q2 2026 in Review

Argent Advisors increased its Pfizer (PFE) stake by 2.7% in Q2 2026, buying an estimated $76.2K and bringing the position to 109,643 shares worth $2.64M. The position accounts for 0.66% of the portfolio, ranked #37.

Argent Advisors first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.54M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Argent Advisors held 109,643 shares of Pfizer worth $2.64M as of Q2 2026.
  • Argent Advisors bought 2,913 Pfizer shares in Q2 2026, an estimated $76.2K.
  • Pfizer made up 0.66% of Argent Advisors's portfolio in Q2 2026, its #37 holding.
  • Argent Advisors first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Argent Advisors's Pfizer position peaked at $3.54M in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Argent Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.